Magnetar Financial’s Chinook Therapeutics, Inc. Common Stock KDNY Stock Holding History

Magnetar Financial’s Portfolio KDNY Stock Details KDNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-1,262,060	Closed	-$48.5M	–	664
2023 Q2	$48.5M	Buy	+1,262,060	New	+$32.4M	1.06%	37

Magnetar Financial's KDNY Position: Q3 2023 in Review

Magnetar Financial sold out of Chinook Therapeutics, Inc. Common Stock (KDNY) in Q3 2023, closing a stake of 1,262,060 shares — an estimated $48.5M sold.

Magnetar Financial first reported a position in KDNY in Q2 2023 and held it in 1 quarter. The position peaked at $48.5M in Q2 2023. 2 funds tracked by Wall St. Rank hold KDNY as of Q3 2023.

Magnetar Financial reported no remaining Chinook Therapeutics, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
Magnetar Financial sold 1,262,060 Chinook Therapeutics, Inc. Common Stock shares in Q3 2023, an estimated $48.5M.
Magnetar Financial first reported a position in Chinook Therapeutics, Inc. Common Stock in Q2 2023 and held it in 1 quarter.
Magnetar Financial's Chinook Therapeutics, Inc. Common Stock position peaked at $48.5M in Q2 2023.
2 funds tracked by Wall St. Rank held Chinook Therapeutics, Inc. Common Stock as of Q3 2023.

Based on Magnetar Financial's 13F filing for Q3 2023, filed 14 Nov 2023.